Not only does Slatic's Specialty="Mergers and Acqu
Post# of 1481
https://www.linkedin.com/in/james-slatic-a858315
But also,
On April 1, 2018, the Company verbally agreed to enter into an agreement to appoint Dr. Heiner Dreismann to its business advisory board to assist the Company’s management with evaluating potential merger and acquisition opportunities, developing a plan to secure a medical device designation from Health Canada for CannaDx, and other advice related to the Company’s business.
https://en.wikipedia.org/wiki/Heiner_Dreismann
https://backend.otcmarkets.com/otcapi/company...ntent/html
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)